# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst David Saxon reiterates Dentsply Sirona (NASDAQ:XRAY) with a Buy and maintains $34 price target.
Needham analyst David Saxon maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $36 to $34.
Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.
- 10Q Filing